ABC | Volume 111, Nº5, November 2018

Original Article Lopes et al Mortality for critical congenital heart diseases and newborns Arq Bras Cardiol. 2018; 111(5):666-673 1. Jenkins K. Mortality with congenital heart defects in England and Wales, 1959–2009. Much progress, but more to do. Arch Dis Child. 2012;97(10):859-60. 2. Knowles RL, Bull C, Wren C, Dezateux C. Mortality with congenital heart defects in England and Wales, 1959–2009: exploring technological change through period and birth cohort analysis. Arch Dis Child. 2012;97(10):861-5. 3. Fixler DE, Xu P, Nembhard WN, Ethen MK, Canfield MA. Age at referral and mortalityfromcriticalcongenitalheartdisease.Pediatrics.2014;134(1):e98-105. 4. MacColl CE, Manlhiot C, Page C, McCrindle BW, Miner SE, Jaeggi ET, et al. Factors associated with in utero demise of fetuses that have underlying cardiac pathologies. Pediatr Cardiol. 2014;35(8):1403-14. 5. Leite Dde L, Miziara H, Veloso M. Congenital cardiac malformations in pediatric necropsies: characteristics, associations and prevalence. Arq Bras Cardiol. 2010;94(3):275-80, 294-9. 6. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart disease and stroke statistics 2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38-360. 7. Hoffman JIe. The global burden of congenital heart disease : review article. Cardiovasc J Afr. 2013;24(4):141-5. 8. Torres-Cosme JL, Rolón-Porras C, Aguinaga-Ríos M, Acosta-Granado PM, Reyes-Muñoz E, Murguía-Peniche T. Mortality fromcongenital heart disease in Mexico: a problem on the rise. Plos One. 2016;11(3):e0150422. 9. Salim TR, Soares GP, Klein CH, Oliveira GM. Mortality from circulatory systemdiseases andmalformations in children in the State of Rio de Janeiro. Arq Bras Cardiol. 2016;106(6):464-73. 10. StavskyM, Robinson R, SadeMY, KrymkoH, Zalstein E, Ioffe V, et al. Elevated birth prevalence of conotruncal heart defects in a population with high consanguinity rate. Cardiol Young. 2017;27(1):109-16. 11. Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013;131(5):e1502-8. 12. ChengHH, AlmodovarMC, Laussen PC,Wypij D, Polito A, BrownDW, et al. Outcomes and risk factors for mortality in premature neonates with critical congenital heart disease. Pediatr Cardiol. 2011;32(8):1139-46. 13. Polito A, Piga S, Cogo PE, Corchia C, Carnielli V, Da Frè M, et al. Increased morbidity andmortality in very preterm/VLBW infants with congenital heart disease. Intensive Care Med. 2013;39(6):1104-12. 14. Zou G. AModified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-6. 15. McNuttLA,WuC,XueX,HafnerJP.Estimatingtherelativerisk incohortstudies andclinicaltrialsofcommonoutcomes.AmJEpidemiol.2003;157(10):940-3. 16. Christiansen TB, Lauritsen JM (eds.). Comprehensive Data Management and Basic Statistical Analysis System. Odense Denmark: EpiData Association; 2010. [Internet]. [Cited in 2017 Mar 18]. Available from: http://www.epidata.dk. 17. R Development Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2016. [Cited in 2017 Mar 18]. Available from: http://www.R-project.org 18. Zuppa AA, Riccardi R, Catenazzi P, D’Andrea V, Cavani M, D’Antuono A, et al. Clinical examination and pulse oximetry as screening for congenital heart disease in low-risknewborn. JMaternFetalNeonatalMed.2015;28(1):7-11. 19. Albuquerque FC, Maia ET, Figueiredo VL, Mourato FA, Mattos SS. Clinical examination and pulse oximetry to detect congenital heart defects. Int J Cardiovasc Sci. 2015;28(2):48-151. 20. Ewer AK. Review of pulse oximetry screening for critical congenital heart defects in newborn infants: Curr Opin Cardiol. 2013;28(2):92-6. 21. Dawson AL, Tinker SC, Jamieson DJ, Hobbs CA, Berry RJ, Rasmussen SA, et al; National Birth Defects Prevention Study. Twinning and major birth defects, National Birth Defects Prevention Study, 1997–2007. J Epidemiol Community Health. 2016;70(11):1114-21. 22. Eckersley L, Sadler L, Parry E, Finucane K, Gentles TL. Timing of diagnosis affects mortality in critical congenital heart disease. Arch Dis Child. 2016;101(6):516-20. 23. Malta DC, Duarte EC, Almeida MF, Dias MA, Morais Neto OL, Moura L, et al. Lista de causas de mortes evitáveis por intervenções do Sistema Único de Saúde do Brasil. 2007. Epidemiol Serv Saúde Brasília; 16(4):233-44. 24. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Manual de vigilância do óbito infantil e fetal e doComitê de Prevenção doÓbito Infantil e Fetal. 2ª. ed. Brasília; 2009. 96 p. (Série A: Normas e Manuais Técnicos). 25. Malta DC, Duarte EC, Escalante JJ, AlmeidaMF, Sardinha LMV, Macário EM, et al. [Avoidable causes of infant mortality in Brazil, 197-2006: contributions to performance evaluation of the Unified National Health System]. Cad Saude Publica. 2010;26(3):481-91. 26. Boing AF, Boing AC. [Infant mortality from preventable causes in Brazil: an ecological study in 2000-2002. Cad Saude Publica. 2008;24(2):447-55. 27. Brasil, Ministério da Saúde. Portaria nº 1.727, de 11 de julho de 2017. Aprova o plano nacional de assistência à criança comcardiopatia congênita. Diário Oficial da União. DOU. n. 132, 12 de jul. 2017. Seção I, p. 47. 28. Caneo LF, Jatene MB, Riso AA, Tanamati C, Penha J, Moreira LF, et al . Evaluation of surgical treatment of congenital heart disease in patients aged above 16 years. Arq Bras Cardiol. 2012;98(5):390-7. 29. Pinto Júnior VC, Branco KM, Cavalcante RC, Carvalho Junior W, Lima JR, Freitas SM, et al. Epidemiology of congenital heart disease in Brazil. Rev Bras Cir Cardiovasc. 2015;30(2):219-24. References 672